Navigation Links
Multiple sclerosis -- antihypertensive drug ameliorate inflammation in the brain
Date:7/28/2010

Researchers in Heidelberg and Stanford have discovered a new signalling pathway of brain cells that explains how widely used antihypertensive drugs could keep inflammation in multiple sclerosis (MS) in check. The peptide angiotensin not only raises blood pressure but also activates the immunological messenger substance TGF beta on a previously unknown communication pathway in the brain. The study was conducted by Professor Lawrence Steinman at Stanford University in California together with the group of Professor Platten and published in the "Journal of Clinical Investigation". The Heidelberg team of researchers consisted of Dr. Tobias Lanz, lead author of the study and Professor Dr. Michael Platten, lead author of the previous study on that topic. Professor Platten is the senior consultant at the Department of Neurooncology at Heidelberg University Hospital and the head of the Helmholtz University Young Investigators Group "Experimental Neuroimmunology" at the German Cancer Research Center (DKFZ) in Heidelberg.

Angiotensin II is known as a molecule that regulates blood pressure. Drugs that block the angiotensin receptors, (AT1R blockers), are prescribed to millions of people to lower high blood pressure. These receptors have now also been found on numerous organs and cells that have nothing to do with regulating blood pressure, for example on the T cells of the immune system. These are immune cells that are involved in autoimmune reactions and chronic-inflammatory diseases such as MS. MS is characterized by multifocal areas of inflammation in the brain and spinal cord that lead to paralysis and other neurological symptoms.

Paralysis resolved in an animal model

The scientists working with Professor Platten showed in a mouse model that angiotensin II promotes inflammation in the brain and spinal cord. When the angiotensin receptors, i.e. the sites where angiotensin docks onto cells and can develop its effect, were block
'/>"/>

Contact: Prof. Dr. med. Michael Platten
michael.platten@med.uni-heidelberg.de
062-215-66804
University Hospital Heidelberg
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Breast cancer cells regulate multiple genes in response to estrogen-like compounds
2. University at Buffalo launches clinical trial of new multiple sclerosis treatment
3. Clinical Trial Testing New Multiple Sclerosis Treatment to Launch in Buffalo
4. Cancer and Multiple Sclerosis Survivor Martin Smith's 3,000-mile Bicycle Ride Benefits Cancer Research
5. Can multiple sclerosis attacks be minimized in a war zone?
6. Quincy Bioscience Sponsors Multiple Sclerosis (MS) Scholarship Program
7. 96 percent of vasectomy patients cleared without need for multiple semen samples
8. Protein lets brain repair damage from multiple sclerosis, other disorders
9. Simple eye test measures damage from multiple sclerosis, UT Southwestern researchers find
10. Projects In Knowledge Launches Free iPhone App of Living Medical Textbook Neurology: Multiple Sclerosis 2010 Edition
11. $1.9 million grant to help UCF find multiple sclerosis nerve-ana
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2014)... York, NY (PRWEB) July 12, 2014 ... steady growth over the past five years, buoyed by ... agricultural sector's supply management system. “Eggs are a relatively ... result, per capita egg consumption generally grows in line ... Industry Analyst Will McKitterick. Furthermore, demand for new specialty ...
(Date:7/12/2014)... 2014 The rise in the number ... new advanced network architectures to suit the upsurge. Virtualization ... with increasing cloud storage technologies. The data traffic has ... mobility devices. This has resulted in larger and more ... forces for the SDN market. , The North American ...
(Date:7/12/2014)... The "North American ... Market by Angioplasty Balloon (Plain/Old, Cutting), ... IVC Filter (Retrievable), Endovascular Stent Graft ... studies the major market drivers, restraints, ... Canada. , Browse 108 market data ...
(Date:7/12/2014)... The Security Analytics market is estimated to ... by 2019, at an expected CAGR of 9.7% for ... counter the increasing number of security breaches, continued line ... systems in organizations are enormous. Vendors in the security ... architecture to develop better and more secure systems. , ...
(Date:7/12/2014)... Melbourne, Australia (PRWEB) July 12, 2014 ... past five years, despite rising competition from international and ... compound annual 2.9% over the five years through 2014-15. ... with consumers demanding more gaming services. Rises in discretionary ... have spent more money on non-essential items such as ...
Breaking Medicine News(10 mins):Health News:Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 4Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 5Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 2Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 3Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 5Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 4Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 4
... Failure by Sutter Medical Center Santa Rosa and Santa ... of county services fuels efforts to make ... SANTA ROSA, Calif., March 12 In the ... workers,at Santa Rosa Memorial Hospital -- already engaged in ...
... show whether an antidepressant is working , , TUESDAY, March ... biomarker for depression that could lead to a quick ... making headway against the disease. , "This may be ... co-author Mark Rasenick, director of the Interdisciplinary Neuroscience Program ...
... study in the,Journal of the American Medical Association ... Staphylococus aureus), a simple,skin or nasal swab, is ... for Methicillin-Resistant Staphylococcus aureus at,Hospital Admission and Nosocomial ... March 12, 2008)., The findings of the ...
... (NYSE:,WLP) announced today that senior management is scheduled to present at ... Healthcare Conference on March 13, 2008, ... Daylight Time (EDT);, -- Lehman Brothers ... March 19, 2008, at 10:15 a.m. EDT., All interested parties ...
... a good news, bad news situation. Some women who ... dont have cancer, they do have atypical hyperplasia -- ... someday. This happens to one-fourth of women undergoing breast ... risk. , In their quest to discover who is ...
... Zimmer Holdings, Inc.,(NYSE ZMH; SWX: ZMH), a leader in the ... upcoming investor,conferences:, -- March 18, 2008 -- Cowen,s ... Massachusetts, 8:00 a.m. Eastern Time -- March 19, 2008 ... Conference, Miami Beach, Florida, 8:30 a.m. Eastern Time, ...
Cached Medicine News:Health News:Santa Rosa Healthcare Workers Seek Accountability From Catholic Hospital System 2Health News:Scientists Spot Biochemical Sign of Depression 2Health News:Scientists Spot Biochemical Sign of Depression 3Health News:JAMA Article Provides False Support for CDC's Do-Nothing Position on MRSA 2Health News:WellPoint Announces Appearances at Upcoming Conferences 2Health News:COX-2 expression is marker for cancer development in some benign breast biopsies 2Health News:COX-2 expression is marker for cancer development in some benign breast biopsies 3Health News:COX-2 expression is marker for cancer development in some benign breast biopsies 4
(Date:7/10/2014)... , July 10, 2014  RESMED INC. (NYSE: ... fourth quarter and fiscal year ended June 30, 2014 results ... Exchange market close. A press release with ResMed,s results will ... company will host a webcast to discuss operating results and ... begin at 1:30 p.m. US Pacific Time and the live ...
(Date:7/10/2014)... 10, 2014   Ventana Medical Systems, Inc.  (Ventana), ... has entered into an agreement with Merck KGaA, Darmstadt, ... Serono in the United States ... Merck KGaA,s biopharmaceutical division on the development and commercialization ... using Ventana,s proprietary diagnostic assays. In alignment with Merck ...
(Date:7/10/2014)... 2014 Decision Resources Group finds that over ... Food and Drug Administration,s (FDA) approval of Vifor Fresenius ... was approved by the FDA in November 2013 for ... patients on dialysis. Other key findings from ... 2014 : , ...
Breaking Medicine Technology:ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3
... pleased to announce first quarter 2012 revenues of $210,635, ... The increase in revenues was driven by surgeries at ... using the Kelyniam Custom Skull Implant made from PEEK ... quarter with the new management and a full sales ...
... SNDY) is pleased to announce that the Company has successfully ... $570,000.  As a result, the Company expects to achieve a ... financials, and show significant reduction of its liabilities for the ... issued Preferred Stock valued at $10 per share in order ...
Cached Medicine Technology:Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012 2Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012 3Solos Endoscopy Reduces Liabilities by More than $570,000 2Solos Endoscopy Reduces Liabilities by More than $570,000 3
The new XMI catheter incorporates the best in catheter technology to ,provide exceptional handling characteristics comparable to todays balloon catheters and stent delivery systems....
The new XVG catheter is our highest power thrombectomy catheter designed for accessing distal anatomy. Utilizing proprietary Cross-Stream water jet technology, the XVG catheter removes thrombus quick...
Redel Connector 10 Pin...
... a non-fluoroscopic navigation system that tracks multiple ... Fred Wittkampf, Ph.D., and is being developed ... ,The LocaLisa system uses three ... around the heart to track catheters. Using ...
Medicine Products: